Pure Global

Imin 17α-Hydroxyprogesterone radioimmunoassay reagent - Taiwan Registration 7351a9f4270ee7aa1f7e5197abc1f511

Access comprehensive regulatory information for Imin 17α-Hydroxyprogesterone radioimmunoassay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7351a9f4270ee7aa1f7e5197abc1f511 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.. The authorized representative in Taiwan is ALICE LEE INDUSTRIES CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
7351a9f4270ee7aa1f7e5197abc1f511
Registration Details
Taiwan FDA Registration: 7351a9f4270ee7aa1f7e5197abc1f511
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Imin 17α-Hydroxyprogesterone radioimmunoassay reagent
TW: 伊敏17α-羥基黃體脂酮放射免疫分析試劑
Risk Class 2
Cancelled

Registration Details

7351a9f4270ee7aa1f7e5197abc1f511

DHAS0602253605

Company Information

United States

Product Details

Radioimmunoassay was used to quantitatively detect 17α-hydroxyluteinous progesterone in human serum and plasma in vitro

A Clinical chemistry and clinical toxicology

A.1395 17-Progesterone Test System

Input;; Consent letter must be attached to the import (consent from the Atomic Energy Commission must be obtained for each import)

Dates and Status

Aug 08, 2011

Aug 08, 2016

Jul 31, 2018

Cancellation Information

Logged out

未展延而逾期者